AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead?

Rhea-AI Summary

AIX Inc. (NASDAQ:AIFU) has completed a strategic asset restructuring worth $140 million, exchanging assets including the Duxiaobao AI insurance platform for a 72% stake in BGM Group. The company reported total revenue of $3.198 billion (up 14.98% YoY) and net profit of $289 million (up 237.25% YoY) as of December 31, 2023. The restructuring combines AIFU's insurance expertise with BGM's pharmaceutical leadership, positioning them in both AI insurance and healthcare sectors. The Duxiaobao platform, built on Baidu's big data capabilities, aims to provide intelligent insurance solutions. With a current market value of $76 million and a P/E ratio of 3.5x, AIFU appears significantly undervalued compared to industry peers.

Positive

• Revenue growth of 14.98% YoY to $3.198 billion
• Net profit increase of 237.25% YoY to $289 million
• Acquisition of 72% stake in BGM Group through $140 million asset restructuring
• Low P/E ratio of 3.5x indicates potential undervaluation

Negative

• Current market value of only $76 million shows market recognition
• Significant valuation gap compared to industry peers might indicate market skepticism

HONG KONG, Nov. 29, 2024 /PRNewswire/ -- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims services. Recently, the company has been gradually pushing for an intelligent and diversified transformation, aiming to capture growth opportunities in the AI insurance and healthcare sectors. The restructuring of its high-quality assets and a strategic partnership with BGM Group Ltd. (NASDAQ:BGM) are expected to create a second growth curve for the company's future performance.

1. Restructuring Quality Assets to Build a Smarter Future

AIFU has recently undertaken the restructuring of its core assets, involving an amount of $140 million, including RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology") and Shenzhen Xinbao Investment Management Co., Ltd. ("Xinbao Investment").

This is not a simple "sale" transaction; the restructuring involves the Duxiaobao AI insurance platform, which provides intelligent solutions to the insurance market through AI and big data. AIFU exchanged these assets for 72% of BGM Group's shares, becoming the majority shareholder of BGM Group. This transaction is expected to significantly increase BGM Group's market value and open up new opportunities for AIX Inc.'s future development.

Key Points of Asset Restructuring:

1. Business Growth Potential: The Duxiaobao AI insurance platform has strong technical barriers (based on Baidu's big data platform) and market potential (AIFU's insurance brokerage platform) and is expected to drive significant performance growth for BGM Group in the coming years. AIFU retains control of the future development of Duxiaobao through its stake in BGM.
2. Undervaluation: BGM Group currently has a market value of only $52 million, yet its new business has a market potential that far exceeds its current valuation. As the majority shareholder of BGM, AIFU stands to benefit from BGM's business growth.
3. Dual Business Synergy: BGM Group is a global leader in the pharmaceutical industry. Through deep cooperation with BGM Group, AIFU has strengthened its presence in both the AI insurance and healthcare sectors, with the potential to become a leader in these two industries.

2. BGM Group: From a Market Value of Millions to a Potential Leader in AI Insurance

• Technical Advantage: BGM is positioned to take a leading role in the AI + insurance market transformation by leveraging the Duxiaobao AI insurance platform and Baidu's big data capabilities. It can offer personalized insurance solutions to the market.
• Market Opportunity: The global AI insurance industry is on the brink of a major expansion, and BGM is well-positioned to seize this opportunity.
• Industry Trend: The "pharmaceutical + insurance" model is gaining momentum in China, where over 400 million people have chronic conditions. Annual medical expenses account for 60% of total expenses, yet related premiums constitute only 5% of health insurance, revealing a significant protection gap. From 2012 to 2022, China's commercial health insurance experienced a compound annual growth rate (CAGR) of 25.93%, far surpassing the average growth rate of the insurance industry, indicating tremendous growth potential. Successful cases such as CVS's acquisition of Aetna and UnitedHealth Group's integration with OptumRx validate the critical value of "pharma + insurance" collaborations in optimizing costs, innovating supply chains, and facilitating data sharing.

Currently, BGM Group's market value has not yet been fully realized in the secondary market. If the AI insurance business expands rapidly, BGM Group's market value and stock price are likely to undergo significant revaluation.

3. AIFU's Undervaluation

As of December 31, 2023, AIFU's total revenue reached $3.198 billion, reflecting a year-on-year increase of 14.98%, and net profit was $289 million, demonstrating a year-on-year increase of 237.25%. As the largest insurance brokerage platform in China, AIFU has a Price-to-Earnings (P/E) ratio of only 3.5x. In comparison, Prudential Insurance reported revenue of $11.9 billion, up 143%, with a net profit of $1.712 billion, up 271.72%. Meanwhile, Prudential Financial's revenue was $53.979 billion, down 5.1%, but its net profit rose by 249%, reaching $2.508 billion. These results highlight AIFU's significant growth potential.

With a market value of approximately $76 million, AIFU stands in stark contrast to Prudential Insurance (PUK, market value of $21.7 billion) and Prudential Financial (PRU, market value of $46.1 billion). While Prudential focuses primarily on traditional insurance products, AIFU is poised to disrupt the industry with AI-driven solutions, supported by Baidu's big data, which will effectively reduce costs, expand market share, and improve customer satisfaction.

4. Pharmaceutical and Healthcare Strategy Driving Valuation Growth

AIFU not only focuses on the AI insurance business but also heavily invests in the pharmaceutical and healthcare sectors, seizing new opportunities brought about by global population aging. Key driving factors include: 

• Aging Population: An increase in the elderly population leads to a greater demand for insurance and healthcare services.
• AI + Health Management: AIFU plans to use AI technology to offer customized insurance products and services for its client base.

Through the strategic restructuring with BGM Group, AIFU has formed a powerful alliance in both the AI insurance and healthcare sectors, positioning itself to become an industry leader. Whether in terms of BGM Group's valuation potential or AIFU's business expansion, this transaction presents a unique opportunity for investors. The dual drivers of AI insurance and healthcare will be the cornerstone of the company's future development.

View original content:https://www.prnewswire.com/news-releases/aix-inc-nasdaqaifu-reshaping-ai-insurance-and-the-healthcare-industrya-promising-future-ahead-302318841.html

SOURCE AIX Inc.

FAQ

What was AIFU's revenue and profit growth in 2023?

AIFU reported revenue of $3.198 billion (up 14.98% YoY) and net profit of $289 million (up 237.25% YoY) as of December 31, 2023.

What is the value of AIFU's recent asset restructuring deal?

AIFU completed an asset restructuring worth $140 million, exchanging assets for a 72% stake in BGM Group.

How does AIFU's market value compare to its competitors?

AIFU's market value is approximately $76 million, significantly lower than competitors like Prudential Insurance ($21.7 billion) and Prudential Financial ($46.1 billion).

What is AIFU's current P/E ratio?

AIFU has a Price-to-Earnings (P/E) ratio of 3.5x.